Drug Companies Aren't Apologizing for Their Role in the Opioid Crisis, Billions of Dollars in Settlements or Not

Newsweek 1 month ago

The world's biggest drug companies largely deny any wrongdoing regarding their role in fueling the opioid epidemic—multimillion-dollar settlements or not.

Drugmakers Johnson & Johnson and Purdue Pharma, along with distributors McKesson, AmerisourceBergen and Cardinal Health, have all agreed to reimburse states, counties and the federal government for dishonest marketing and failure to regulate the deadly painkillers, which have taken hundreds of thousands of U.S. lives.

Reimbursement is one thing, but admission of guilt is another. In nearly a dozen cases reviewed by Newsweek, all the drug companies have clauses in their opioid-related settlements over the years that allow them to avoid saying they did anything wrong.

Earlier this week, drug distributors agreed to pay Ohio counties $260 million, minus a contribution from drugmaker Teva Pharmaceuticals. Cuyahoga and Summit counties have been ravaged by the opioid crisis, losing tens of thousands of lives and many millions of dollars in opioid-related costs, according to local officials.

Despite the agreement, the distributors "strongly dispute the allegations," which mostly involve dodging their regulatory responsibilities.

"While the companies strongly dispute the allegations made by the two counties, they believe settling the bellwether trial is an important stepping stone to achieving a global resolution and delivering meaningful relief," said McKesson, AmerisourceBergen and Cardinal Health in a joint statement.

"The distributors remain deeply concerned about the impact the opioid epidemic is having on families and communities across the nation—and are committed to being part of the solution," the companies added.

Federal Drug Trial Delayed by Settlements

Earlier this year, McKesson paid $37 million to West Virginia without admitting fault. Two years ago, the company paid the federal government $150 million in civil penalties for alleged violations of the Controlled Substances Act, agreeing to suspend sales and ramp up compliance measures.

In a press release at the time, McKesson said it settled "in the interest of moving beyond disagreements about whether McKesson was complying with the controlled substance regulations...and to instead focus on the company's partnership with regulators and others to help stem the opioid epidemic in this country."

In 2017, AmerisourceBergen and Cardinal Health agreed to pay $16 million and $20 million, respectively, to West Virginia after accusations that they didn't properly monitor the supply of opioids coming into the state. Both companies denied the allegations.

In 2016, Cardinal Health admitted it failed to report suspicious orders to the Drug Enforcement Administration from January 1, 2009, to May 14, 2012, and paid $44 million to the federal government. In a statement, Chief Legal and Compliance Officer Craig Morford drew attention to other players in the opioid pipeline.

"To combat the scourge of opioid abuse successfully, this must be a collaborative effort that includes all parties—the regulators, who set and license supply; the manufacturers, who produce medications; the physicians, who treat patients and prescribe medications; and the pharmacists, who fill those prescriptions," Morford said.

Earlier this year, Johnson & Johnson settled with the two Ohio counties for $20.4 million, including reimbursement for legal fees and charitable contributions to opioid-related nonprofit programs. Amid the crisis, Johnson & Johnson made a fentanyl patch and opioid tablets, but it also produced a lot of the raw opium used by other drug companies.

In a statement at the time, the company said the agreement came with "no admission of liability."

"As previously stated, the company is open to identifying an appropriate, comprehensive resolution of the overall opioid litigation. At the same time, the company remains prepared to defend its actions," a spokesperson said, adding that some of Johnson & Johnson's products accounted for less than 1 percent of total opioid prescriptions in the U.S.

A judge ordered Johnson & Johnson to pay $572 million to Oklahoma earlier this year. The company appealed the verdict, and Cleveland County District Judge Thad Balkman later said the figure was about $100 million too high because of a miscalculation, according to CBS News.

Purdue Pharma, which makes OxyContin, filed for bankruptcy in September to resolve suits with a dozen states and thousands of counties. The company's owners, members of the Sackler family, agreed to pay $3 billion over seven years to the plaintiffs and to sell Mundipharma, its British pharmaceutical firm. Included in the terms of the agreement was no admission of wrongdoing from the Sacklers.

The companies did not immediately respond to request for comment.

The opioid epidemic cost the U.S. economy at least $631 billion over four years, according to the Society of Actuaries. A study published earlier this year by Massachusetts General Hospital estimated that 700,000 people in the U.S. will die from opioid overdoses between 2016 and 2025.

According to another recent report, most people who died from overdoses in a Massachusetts sample used heroin or illicitly fentanyl, suggesting the U.S. could be heading toward another public health crisis. As prescription painkillers become harder to find, those dependent on opioids are turning to deadlier alternatives.

Source link
Read also:
Newsweek › 1 month ago
With recent criticism comparing opioid settlements to the tobacco settlements from decades ago—where billions of dollars went unaccounted for—all eyes are on local officials and their burgeoning settlement coffers.
Cleveland › 1 month ago
A federal judge in Cleveland said Wednesday morning that he would not to delay the nation’s first opioid trial in the face of news over the past day that four of the major drug companies are contemplating settlements for thousands of lawsuits across...
Cleveland › 2 months ago
Drug companies have agreed to pay millions of dollars to Cuyahoga and Summit counties to resolve claims that they fueled the opioid epidemic that caused thousands of overdose deaths.
UPI › Finance › 1 month ago
Several drug companies reached a last-minute settlement with federal prosecutors Monday to avoid going to trial in a legal fight to determine who's responsible for the U.S. opioid crisis.
UPI › Finance › 1 month ago
Several drug companies reached a last-minute settlement with federal prosecutors Monday to avoid going to trial in a legal fight to determine who's responsible for the U.S. opioid crisis.
New York Post › 1 month ago
CLEVELAND – Four drug companies reached a last-minute legal settlement over their role in the opioid addiction epidemic just as a nine-week trial was scheduled to start in Cleveland, the Wall Street Journal reported Monday. Drug distributors...
Forbes › 1 month ago
What role did doctors and pharmaceutical companies play in the current opioid crisis? This question was originally answered on Quora by Ben Westhoff.
New York Daily News › Politics › 1 month ago
WASHINGTON In this week's $260 million settlement between drug companies and two Ohio counties hit hard by the opioid crisis, $25 million worth of the
CNN › Lifestyle › 1 month ago
Six drug companies accused in thousands of lawsuits over their role in the nation's opioid epidemic failed to reach a settlement with governments across the country, setting the stage for a high-profile trial Monday.
New York Daily News › 1 month ago
Four major drug companies have settled with two Ohio counties to avoid going to trial over their role in the opioid crisis.
Sign In

Sign in to follow sources and tags you love, and get personalized stories.

Continue with Google